You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
24 August 2026 - Medical technology company Tempus AI Inc (NASDAQ: TEM) reported on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, an AI-enabled software device designed to analyse standard ...
24 August 2026 - US biopharmaceutical company Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), said on Monday it has received European Commission orphan designation for imsidolimab, its investigational monoclonal antibody for Generalised Pustular Psoriasis...
24 August 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Monday that the European Commission has approved Trodelvy (sacituzumab govitecan-hziy) with Keytruda (pembrolizumab) for adults with unresectable, locally advan...
24 August 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Monday that the US Food and Drug Administration (FDA) has accepted for priority review its supplemental Biologics License Application for Jemperli (dostarlimab) for ...
24 August 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH: HLUN-B) said on Monday it has received European Commission orphan designation for asedebart (Lu AG13909), its investigational anti-ACTH monoclonal antibody for Cushing's syn...
24 August 2026 - South Korean pharmaceutical company Hanmi Pharm Co Ltd announced on Monday that it has entered into an exclusive licensing agreement with Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), for the development, manu...
24 August 2026 - Medical technology company Pulnovo Medical announced on Sunday the enrolment of the first two patients in its PULSE-LHD clinical trial, conducted under a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE), a...